Stock Report

All about this stock under one free report Last Updated: 30-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Fabtech Technologies Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: FABTECH | BSE: 544558

₹147.56

up-down-arrow ₹0.59 (0.40%)

As on 28-Aug-2026IST

Market cap

info icon

₹656 Cr

Revenue (TTM)

info icon

₹418 Cr

P/E Ratio

info icon

13.5

P/B Ratio

info icon

1.5

Div. Yield

info icon

0.4 %

Edit peer-selector-edit
Fabtech Technologies Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Market cap (₹ Cr)
 656 31,434 14,932 13,940 9,704
Revenue (₹ Cr)
 418 2,250 3,172 3,813 950
Net Profit (₹ Cr)
 48.35 361.74 521.27 400.90 266.00
Net Margin (%)
 10.97 15.77 15.92 10.30 27.44
RoE (%)
 15.85 15.47 18.10 13.87 72.69
Price to Earnings
 13.46 86.90 28.90 34.77 36.48
Price-To-Book
 1.55 12.31 4.70 4.34 27.89

Income Statement (₹ Cr)

Fabtech Technologies Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Operating Revenue arrow
410.77 2,192.49 2,950.94 3,510.50 878.40
Total Income arrow
431.33 2,266.90 3,033.47 3,582.50 896.80
Total Expenditure arrow
374.67 1,584.97 2,350.16 2,891.50 569.40
EBITDA arrow
36.11 607.53 600.78 619.00 309.00
Depreciation arrow
5.30 166.86 98.63 126.40 11.70
EBIT arrow
30.80 440.67 502.15 492.60 297.30
Interest arrow
5.27 40.88 24.13 19.30 2.00
Other Income arrow
20.56 74.40 82.53 72.00 18.40
Exceptional Items arrow
1.77 -8.00 -- -20.30 6.60
Profit before Tax arrow
48.27 466.19 560.56 525.00 320.30
Provision for Tax arrow
9.92 117.28 140.49 123.90 80.20
Profit after Tax arrow
38.36 348.91 420.06 401.10 240.10

Liabilities (₹ Cr)

Fabtech Technologies Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Shareholder's Funds arrow
419.77 2,483.69 3,023.16 3,138.70 384.00
Minority Interest arrow
0.00 -- 29.52 -- --
Non-Current Liabilities arrow
23.22 321.65 268.17 318.60 229.90
Current Liabilities arrow
244.03 904.59 527.09 1,086.20 128.40
Total Liabilities arrow
690.89 3,709.93 3,855.82 4,620.30 750.80

Assets (₹ Cr)

Fabtech Technologies Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Non-Current Assets arrow
127.78 2,228.49 1,125.20 1,925.10 248.00
Current Assets arrow
553.60 1,481.44 2,722.74 2,618.40 494.30
Total Assets arrow
690.89 3,709.93 3,855.82 4,620.30 750.80
Total Debt* arrow
42.73 95.13 29.59 0.00 0.00
Net Current Assets arrow
309.57 576.85 2,195.65 1,532.20 365.90
Contingent Liabilities arrow
45.15 97.31 -- -- 1.50

Cashflow (₹ Cr)

Fabtech Technologies Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Cash From Operating Activities arrow
0.48 509.13 458.13 650.80 174.80
Cash Flow from Investing Activities arrow
-112.31 -395.41 -248.27 -512.40 7.60
Cash from Financing Activities arrow
189.66 -123.68 -70.93 -82.60 -134.50
Net Cash Inflow / Outflow arrow
77.83 -9.96 138.93 55.80 47.90

Ratios

Profitability Ratios

 Fabtech Technologies Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
ROCE (%) arrow
15.51 20.97 21.10 18.92 98.11
ROE (%) arrow
12.94 15.16 15.31 14.14 73.20
ROA (%) arrow
6.90 10.09 11.85 10.31 37.26
EBIT Margin (%) arrow
13.79 31.10 23.16 19.68 37.27
Net Margin (%) arrow
8.89 15.39 13.85 11.20 26.77
Cash Profit Margin (%) arrow
10.63 23.50 17.07 15.03 27.35

Growth Ratios

 Fabtech Technologies Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Revenue Growth (%) arrow
25.75 29.38 12.51 23.64 21.24
EBIT Growth (%) arrow
17.94 53.37 14.07 7.72 15.44
Net Profit Growth (%) arrow
-17.43 105.08 9.79 -1.38 32.65
EPS Growth (%) arrow
-39.83 101.82 9.81 -1.79 32.65
Book Value Growth (%) arrow
142.48 16.76 22.41 19.89 41.18

Valuation Ratios

 Fabtech Technologies Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Price / Earnings arrow
16.17 58.91 17.04 26.06 43.36
Price / Book Value arrow
1.48 8.29 2.36 3.38 27.11
Dividend Yield (%) arrow
0.43 0.00 0.57 0.52 1.66
EV/EBITDA arrow
8.02 30.12 9.02 14.57 30.65
Market Cap (₹ Cr) arrow
620.31 20,554.39 7,121.50 10,450.76 10,410.62

Solvency Ratios

 Fabtech Technologies Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Debt to Equity arrow
0.10 0.04 0.01 0.00 0.00
Short term debt to equity ratio arrow
0.10 0.03 0.01 -- --
Current Ratio arrow
2.27 1.64 5.17 2.41 3.85
Quick Ratio arrow
2.18 1.47 3.32 2.41 3.37
Interest Coverage arrow
10.17 12.40 24.24 28.20 161.15

Operating Efficiency Ratios

 Fabtech Technologies Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Debtors to sales (%) arrow
58.80 17.04 21.84 27.97 3.37
Asset Turnover arrow
0.74 0.63 0.86 0.90 1.43
Receivable days arrow
174.27 60.56 71.16 90.10 8.58
Inventory Days arrow
35.88 22.43 109.20 0.00 20.38
Payable days arrow
181.60 194.31 91.82 -- 118.89
Cash Conversion Cycle arrow
28.56 -111.32 88.55 -- -89.93
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...